Frontlight ResearchEarly access
Trial site
Istituti Clinici Scientifici Maugeri S.p.A. Societa' Benefit In Forma Abbreviata Istituti Clinici Scientifici Maugeri S.p.A. Sb O Anche Ics Maugeri S.p.A. Sb O Maugeri S.p.A. Sb
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- ALS (motor neurone disease)1 trial
- Alzheimer disease1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Celldex Therapeutics1 trial
- Celldex Therapeutics Inc.1 trial
- Novartis Pharmaceuticals1 trial
- Prinnovation GmbH1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026